High dosage GLP-1 analogs are now available

被引：0
|
作者：
Pampel S.L. [1 ]
机构：
来源：
MMW - Fortschritte der Medizin | 2016年 / 158卷 / 7期
关键词：
D O I：
10.1007/s15006-016-8074-7
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：72 / 72
相关论文
共 50 条
  • [21] GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy
    Lafferty, Ryan. A. A.
    Flatt, Peter. R. R.
    Irwin, Nigel
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (05) : 587 - 597
  • [22] Synthesis of histidine analogs for SAR studies in relation to GLP-1 activation
    MacLeod, Brianna L.
    Boyd, Victoria
    Haines, David R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [23] GLP-1 Analogs Represent a Novel Treatment Strategy for Diabetic Encephalopathy
    Okouchi, Masahiro
    Okayama, Naotsuka
    Shigeki, Goji
    Iwama, Tadashi
    Katsuno, Tetsuya
    Asada, Kaoru
    Hattori, Kohei
    Goto, Akitomo
    Kamiya, Yasutaka
    Ohno, Tsuneo
    Joh, Takashi
    DIABETES, 2012, 61 : A145 - A145
  • [24] Role of GLP-1 Analogs in the Management of Diabetes and its Secondary Complication
    Sivakumar, Ponnurengam Malliappan
    Premkumar, B.
    Prabhawathi, Veluchamy
    Prabhakar, Pranav Kumar
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (20) : 3166 - 3182
  • [25] Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
    Rowlands, Jordan
    Heng, Julian
    Newsholme, Philip
    Carlessi, Rodrigo
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [26] Hepatoprotective Benefits of SGLT-2 Inhibitors and GLP-1 Analogs
    Rajagopal, Divya
    Al Rashid, Sulthan
    JOURNAL OF DIABETOLOGY, 2024, 15 (04) : 458 - 459
  • [27] Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies
    Bak, M. J.
    Albrechtsen, N. J. Wewer
    Pedersen, J.
    Knop, F. K.
    Vilsboll, T.
    Jorgensen, N. B.
    Hartmann, B.
    Deacon, C. F.
    Dragsted, L. O.
    Holst, J. J.
    DIABETES OBESITY & METABOLISM, 2014, 16 (11): : 1155 - 1164
  • [28] GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?
    Muzurovic, Emir
    Yumuk, Volkan Demirhan
    Rizzo, Manfredi
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (12)
  • [29] Discovery of Nonpeptide, Orally Available Small Molecule GLP-1 Receptor Agonists
    Im, A-Rang
    Park, Jung-Eun
    Hong, Dahae
    Je, In-Gyu
    Kim, Jung Ho
    Chang, Min Whan
    Hong, Chang-Hee
    Shin, Jae Eui
    Sohn, Te-Ik
    Jun, Yearin
    Jang, Eunhye
    Yoo, Yeongran
    Jeon, Woojin
    An, Kyungmi
    DIABETES, 2021, 70
  • [30] GLP-1 in NIDDM
    Holst, JJ
    DIABETIC MEDICINE, 1996, 13 (09) : S156 - S160
12345